Company / SG&A per Share
PharmaCyte Biotech, Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.76
FY2025
5-year range
$0.05 / $1.06
FY2021-FY2025
Trend
+1047.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share changed +1048% YoY in FY2025, a notable deviation from the 9-year average annual change of +10266%.
Based on SEC 10-K filings.
0.76 in FY2025 with a 5-year CAGR of +265.7%.
Increased from $0.05 to $0.76 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +42.5%
- 5-Year CAGR
- +265.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share increased 1047.8% year-over-year.
- Peak sg&a per share was recorded in FY2021.
- Lowest sg&a per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.76 | +1047.8% |
| FY2024 | $0.07 | +25.9% |
| FY2023 | $0.05 | -80.0% |
| FY2022 | $0.26 | -75.3% |
| FY2021 | $1.06 | +91456.0% |
| FY2020 | $0.00 | -35.2% |
| FY2019 | $0.00 | +118.2% |
| FY2018 | $0.00 | -71.9% |
| FY2017 | $0.00 | +12.0% |
| FY2016 | $0.00 | +192.8% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026